The US, alternatives, fixed income and unloved assets all have the potential to disrupt markets in the coming year.

The US, alternatives, fixed income and unloved assets all have the potential to disrupt markets in the coming year.
M&G’s positive outlook; Wisdom from Schroders’s podcast; Alliance Bernstein on the power of curiosity; Janus Henderson on responsible AI; China’s retirement revolution; Apple and much more.
This week, FSA provides a quick comparison of two healthcare funds: the BNP Paribas Healthcare Innovators fund and the Schroder ISF Healthcare Innovation fund.
Keiko Kondo, Schroders’ head of multi-asset investments for Asia, is bullish on US equities, Asian credit and gold, but pessimistic on oil.
This week, FSA provides a quick comparison of two small and mid-cap North American funds: the BlackRock US Mid-Cap Value fund and the Schroders US Small & Mid-cap Equity fund.
Very much ‘the’ story of 2023, this year has proved to be more challenging for these mega-cap stocks.
Dimensional excludes the Middle Kingdom; JP Morgan’s optimistic outlook; Household wealth is rocketing; Schroders is thinking about privates; Ninety One’s pithy AI; German woes and much more.
Rate cuts and higher growth are among factors supporting continued performance.
Schroders’ semi-liquid global private equity strategy will be available via the ADDX platform.
Group warned of Q4 £8bn outflow from legacy Scottish Widows mandate.
Part of the Mark Allen Group.